Drug details:
Molecular formula: C₉H₁₀Cl₂N₂O₂

Standard name: 3-(2,4-dichloroanilino)-N-hydroxypropanamide

Curated SMILES: C1=CC(=C(C=C1Cl)Cl)NCCC(=O)NO

Evidence for compound's anti-virulence activity:

Helicobacter
Related VF: Urease
Target: Urease
Drug effect: Exhibits significant anti-urease potential.
Max phase: Preclinical (in vivo)
Publication:
Liu Q, et al., 2018. Arylamino containing hydroxamic acids as potent urease inhibitors for the treatment of Helicobacter pylori infection. Eur J Med Chem 156:126-136.